SEC Form 4 · accession 0001000229-16-000172
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lucia van Geuns
Director
Period of report
Mar 31, 2016
Accepted (ET)
Apr 1, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Mar 31, 2016 | M | 1,088 | $0.00 | A | 1,183 | D | |
| Common Shares | Mar 31, 2016 | F | 566 | $112.41 | D | 617 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted SharesF1 | $0.00 | Mar 31, 2016 | M | 1,088 | D | — | — | Common Shares | 1,088 | 0 | D |
| Restricted SharesF2 | $0.00 | Apr 1, 2016 | A | 1,335 | A | — | — | Common Shares | 1,335 | 1,335 | D |
Explanation of responses
- F1The Restricted Shares vested at the end of a three-year vesting period ending March 31, 2016.
- F2The Restricted Shares will vest, without performance criteria, at the end of a three-year vesting period ending April 1, 2019, subject to the terms of issuance.